Compounds > levodopa
Page last updated: 2024-08-17

levodopa and Autosomal Dominant Cerebellar Ataxia, Type II

levodopa has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (69.23)29.6817
2010's3 (23.08)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Ikezawa, J; Shimazaki, R; Sugaya, K; Takahashi, K; Tobisawa, S1
Jankovic, J; Niemann, N1
Jeon, BS; Park, H; Park, SH; Shin, JH1
Kitahara, M; Nishizawa, M; Shimohata, T; Tokunaga, J1
Adam, OR; Ferrara, JM; Ondo, WG1
Chang, HC; Chen, RS; Lu, CS; Tsai, CH; Wu Chou, YH; Yen, TC1
Culjković, B; Djarmati, A; Dragasević, N; Kostić, VS; Romac, S; Savić, D; Svetel, M1
Barker, RA; Brown, JM; Wilkins, A1
Bird, TD; Bower, J; Calne, DB; de la Fuente-Fernandez, R; Farrer, M; Furtado, S; Gwinn-Hardy, K; Hanson, M; Hardy, J; Klimek, ML; Lockhart, PJ; Nutt, JG; Payami, H; Singleton, A; Singleton, AA; Stoessl, AJ; Suchowersky, O; Tsuboi, Y; Utti, RJ; Wszolek, ZK1
Berciano, J; Combarros, O; Corral, J; Infante, J; Pascual, J; Polo, JM; Volpini, V1
Lee, SJ; Liao, KK; Liu, RS; Shan, DE; Soong, BW; Sun, CM2
Pavanni, R; Tan, EK; Tong, J; Wong, MC; Zhao, Y1

Reviews

2 review(s) available for levodopa and Autosomal Dominant Cerebellar Ataxia, Type II

ArticleYear
Juvenile parkinsonism: Differential diagnosis, genetics, and treatment.
    Parkinsonism & related disorders, 2019, Volume: 67

    Topics: Adolescent; alpha-Synuclein; Antiparkinson Agents; Child; Child, Preschool; Deep Brain Stimulation; Diagnosis, Differential; DiGeorge Syndrome; Dystonic Disorders; Genetic Diseases, X-Linked; Hepatolenticular Degeneration; Humans; Huntington Disease; Levodopa; Parkinsonian Disorders; Protein Deglycase DJ-1; Protein Kinases; Spinocerebellar Ataxias; Ubiquitin-Protein Ligases; Young Adult

2019
Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2).
    Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:6

    Topics: Antiparkinson Agents; Brain; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dystonia; Humans; Levodopa; Magnetic Resonance Imaging; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Parkinsonian Disorders; Posture; Spinocerebellar Ataxias; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tremor

2004

Other Studies

11 other study(ies) available for levodopa and Autosomal Dominant Cerebellar Ataxia, Type II

ArticleYear
Dopa-responsive dystonia in spinocerebellar ataxia 6: A case report.
    Clinical neurology and neurosurgery, 2023, Volume: 229

    Topics: Aged; Cerebellar Ataxia; Dystonia; Female; Humans; Levodopa; Spinocerebellar Ataxias

2023
A patient with 41 CAG repeats in SCA17 presenting with parkinsonism and chorea.
    Parkinsonism & related disorders, 2016, Volume: 22

    Topics: Amantadine; Antiparkinson Agents; Benzothiazoles; Brain; Chorea; Humans; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Positron-Emission Tomography; Pramipexole; Spinocerebellar Ataxias; TATA-Box Binding Protein; Trinucleotide Repeats

2016
Cervical dystonia associated with spinocerebellar ataxia type 2 successfully treated with levodopa: a case report.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Oct-30, Volume: 24, Issue:14

    Topics: Antiparkinson Agents; Electromyography; Humans; Levodopa; Male; Middle Aged; Neck Muscles; Spinocerebellar Ataxias; Torticollis

2009
Levodopa-induced dyskinesias in spinocerebellar ataxia type 2.
    Archives of neurology, 2010, Volume: 67, Issue:1

    Topics: Antiparkinson Agents; Atrophy; Depressive Disorder; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Parkinsonian Disorders; Rhombencephalon; Spinocerebellar Ataxias

2010
Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2.
    Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:5

    Topics: Aged; Atrophy; Cerebellum; Corpus Striatum; Dopamine Agonists; Genotype; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Organotechnetium Compounds; Parkinsonian Disorders; Pedigree; Pons; Radiopharmaceuticals; Spinocerebellar Ataxias; Substantia Nigra; Tomography, Emission-Computed, Single-Photon; Tropanes

2002
SCA2 and SCA3 mutations in young-onset dopa-responsive parkinsonism.
    European journal of neurology, 2003, Volume: 10, Issue:5

    Topics: Adult; Age of Onset; Female; Humans; Levodopa; Machado-Joseph Disease; Male; Middle Aged; Mutation; Parkinsonian Disorders; Spinocerebellar Ataxias; Yugoslavia

2003
SCA2 presenting as levodopa-responsive parkinsonism in a young patient from the United Kingdom: a case report.
    Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:5

    Topics: Adult; Alleles; Antiparkinson Agents; Ataxins; Female; Humans; Levodopa; Nerve Tissue Proteins; Parkinsonian Disorders; Phenotype; Proteins; Spinocerebellar Ataxias; Trinucleotide Repeat Expansion

2004
Spinocerebellar ataxia type 2 with Levodopa-responsive parkinsonism culminating in motor neuron disease.
    Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:7

    Topics: Alleles; Antiparkinson Agents; Atrophy; Brain Stem; Female; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Motor Neuron Disease; Parkinsonian Disorders; Pedigree; Phenotype; Spinocerebellar Ataxias

2004
Presence of spinocerebellar ataxia type 2 gene mutation in a patient with apparently sporadic Parkinson's disease: clinical implications.
    Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:11

    Topics: Aged; Alleles; Antiparkinson Agents; Ataxins; Caudate Nucleus; DNA Mutational Analysis; Dominance, Cerebral; Genetic Carrier Screening; Genetic Testing; Humans; Levodopa; Male; Middle Aged; Nerve Tissue Proteins; Neurologic Examination; Parkinson Disease; Polymerase Chain Reaction; Positron-Emission Tomography; Proteins; Putamen; Spinocerebellar Ataxias; Treatment Outcome; Trinucleotide Repeats; Ubiquitin-Protein Ligases

2004
Genetic analysis of SCA 2 and 3 repeat expansions in essential tremor and atypical Parkinsonism.
    Movement disorders : official journal of the Movement Disorder Society, 2007, Oct-15, Volume: 22, Issue:13

    Topics: Adult; Antiparkinson Agents; Ataxin-3; Ataxins; Cross-Sectional Studies; Diagnosis, Differential; DNA Mutational Analysis; Drug Resistance; Essential Tremor; Female; Genetic Testing; Genotype; Humans; Levodopa; Male; Middle Aged; Motor Skills Disorders; Multiple System Atrophy; Nerve Tissue Proteins; Neurologic Examination; Nuclear Proteins; Parkinsonian Disorders; Phenotype; Polymerase Chain Reaction; Repressor Proteins; Spinocerebellar Ataxias; Supranuclear Palsy, Progressive; Trinucleotide Repeat Expansion; Trinucleotide Repeats

2007
Spinocerebellar ataxia type 2 presenting as familial levodopa-responsive parkinsonism.
    Annals of neurology, 2001, Volume: 50, Issue:6

    Topics: Adult; Aged; Ataxins; Brain; China; Female; Fluorine Radioisotopes; Gait; Humans; Levodopa; Male; Middle Aged; Nerve Tissue Proteins; Parkinsonian Disorders; Pedigree; Proteins; Spinocerebellar Ataxias; Tomography, Emission-Computed; Trinucleotide Repeats

2001